 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Growth factor
|
PDB id
|
|
|
|
2afg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
8 terms
|
 |
|
Biological process
|
multicellular organismal development
|
22 terms
|
 |
|
Biochemical function
|
protein binding
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
35:2086-2094
(1996)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray crystal structure of human acidic fibroblast growth factor.
|
|
M.Blaber,
J.DiSalvo,
K.A.Thomas.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Fibroblast growth factors (FGFs) are mitogenic and chemotactic agents for a wide
variety of cell types and play a primary role in the regulation of angiogenesis.
Angiogenesis is involved in a variety of critical physiological events including
organogenesis, wound healing, ischemic collateral circulation, and solid tumor
growth. High-resolution structural information is key to understanding the
mechanism of action of these growth factors. We report here the X-ray crystal
structure of human acidic FGF (aFGF), with data extending to 2.0 angstroms
resolution. The crystal contains four independent molecules in the asymmetric
unit. Each molecule contains a single bound sulfate ion, in similar
juxtapositions. The bound sulfate is stabilized through hydrogen-bond
interactions with residues Asn 18, Lys 113, and Lys 118 and defines a potential
heparin binding site. The hydrogen bond with the N delta 2 moiety of Asn 18
appears to be the most conserved interaction, being similar to those observed
for sulfate ion bound to human basic FGF (bFGF) and similar but not identical to
interactions observed for bovine aFGF with heparin analogs. Of the added solvent
groups, five ordered water molecules are conserved in each of the four
independent structures of human aFGF. These water molecules, located at buried
positions, provide hydrogen bonding partnerships with several buried polar
groups in the core of the protein. A central interior cavity exists in each of
the four structures, with sizes ranging from approximately 20 to 50 angstroms3.
The cavity sizes appear to be significantly smaller than that observed in the
related protein interleukin-1 beta. The region comprising the high affinity FGF
receptor binding site is structurally very similar to the corresponding region
from human bFGF, whereas the low affinity site is structurally quite different.
The results provide a structural basis for the role of the low affinity binding
site in FGF receptor discrimination.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Lee,
S.I.Blaber,
V.K.Dubey,
and
M.Blaber
(2011).
A polypeptide "building block" for the β-trefoil fold identified by "top-down symmetric deconstruction".
|
| |
J Mol Biol, 407,
744-763.
|
 |
|
|
|
|
 |
E.Honjo,
T.Tamada,
M.Adachi,
R.Kuroki,
A.Meher,
and
M.Blaber
(2008).
Mutagenesis of the crystal contact of acidic fibroblast growth factor.
|
| |
J Synchrotron Radiat, 15,
285-287.
|
 |
|
|
|
|
 |
H.Yoon,
S.I.Blaber,
D.M.Evans,
J.Trim,
M.A.Juliano,
I.A.Scarisbrick,
and
M.Blaber
(2008).
Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
|
| |
Protein Sci, 17,
1998-2007.
|
 |
|
|
|
|
 |
H.Fan,
H.Li,
M.Zhang,
and
C.R.Middaugh
(2007).
Effects of solutes on empirical phase diagrams of human fibroblast growth factor 1.
|
| |
J Pharm Sci, 96,
1490-1503.
|
 |
|
|
|
|
 |
H.Yoon,
G.Laxmikanthan,
J.Lee,
S.I.Blaber,
A.Rodriguez,
J.M.Kogot,
I.A.Scarisbrick,
and
M.Blaber
(2007).
Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
|
| |
J Biol Chem, 282,
31852-31864.
|
 |
|
|
|
|
 |
J.Jacobs
(2007).
Combating cardiovascular disease with angiogenic therapy.
|
| |
Drug Discov Today, 12,
1040-1045.
|
 |
|
|
|
|
 |
J.Lee,
V.K.Dubey,
T.Somasundaram,
and
M.Blaber
(2006).
Conversion of type I 4:6 to 3:5 beta-turn types in human acidic fibroblast growth factor: effects upon structure, stability, folding, and mitogenic function.
|
| |
Proteins, 62,
686-697.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.L.Chavez,
S.Gosavi,
P.A.Jennings,
and
J.N.Onuchic
(2006).
Multiple routes lead to the native state in the energy landscape of the beta-trefoil family.
|
| |
Proc Natl Acad Sci U S A, 103,
10254-10258.
|
 |
|
|
|
|
 |
J.Kim,
J.Lee,
S.R.Brych,
T.M.Logan,
and
M.Blaber
(2005).
Sequence swapping does not result in conformation swapping for the beta4/beta5 and beta8/beta9 beta-hairpin turns in human acidic fibroblast growth factor.
|
| |
Protein Sci, 14,
351-359.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.K.Dubey,
J.Lee,
and
M.Blaber
(2005).
Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.
|
| |
Protein Sci, 14,
2315-2323.
|
 |
|
|
|
|
 |
M.J.Bernett,
T.Somasundaram,
and
M.Blaber
(2004).
An atomic resolution structure for human fibroblast growth factor 1.
|
| |
Proteins, 57,
626-634.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Fernández-Tornero,
R.M.Lozano,
M.Redondo-Horcajo,
A.M.Gómez,
J.C.López,
E.Quesada,
C.Uriel,
S.Valverde,
P.Cuevas,
A.Romero,
and
G.Giménez-Gallego
(2003).
Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate.
|
| |
J Biol Chem, 278,
21774-21781.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.R.Brych,
J.Kim,
T.M.Logan,
and
M.Blaber
(2003).
Accommodation of a highly symmetric core within a symmetric protein superfold.
|
| |
Protein Sci, 12,
2704-2718.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Srimathi,
T.K.Kumar,
K.M.Kathir,
Y.H.Chi,
S.Srisailam,
W.Y.Lin,
I.M.Chiu,
and
C.Yu
(2003).
Structurally homologous all beta-barrel proteins adopt different mechanisms of folding.
|
| |
Biophys J, 85,
459-472.
|
 |
|
|
|
|
 |
A.I.Arunkumar,
S.Srisailam,
T.K.Kumar,
K.M.Kathir,
Y.H.Chi,
H.M.Wang,
G.G.Chang,
I.Chiu,
and
C.Yu
(2002).
Structure and stability of an acidic fibroblast growth factor from Notophthalmus viridescens.
|
| |
J Biol Chem, 277,
46424-46432.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.I.Arunkumar,
T.K.Kumar,
K.M.Kathir,
S.Srisailam,
H.M.Wang,
P.S.Leena,
Y.H.Chi,
H.C.Chen,
C.H.Wu,
R.T.Wu,
G.G.Chang,
I.M.Chiu,
and
C.Yu
(2002).
Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.
|
| |
Protein Sci, 11,
1050-1061.
|
 |
|
|
|
|
 |
C.Liu,
J.A.Gaspar,
H.J.Wong,
and
E.M.Meiering
(2002).
Conserved and nonconserved features of the folding pathway of hisactophilin, a beta-trefoil protein.
|
| |
Protein Sci, 11,
669-679.
|
 |
|
|
|
|
 |
J.Kim,
S.I.Blaber,
and
M.Blaber
(2002).
Alternative type I and I' turn conformations in the beta8/beta9 beta-hairpin of human acidic fibroblast growth factor.
|
| |
Protein Sci, 11,
459-466.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Srimathi,
T.K.Kumar,
Y.H.Chi,
I.M.Chiu,
and
C.Yu
(2002).
Characterization of the structure and dynamics of a near-native equilibrium intermediate in the unfolding pathway of an all beta-barrel protein.
|
| |
J Biol Chem, 277,
47507-47516.
|
 |
|
|
|
|
 |
Y.H.Chi,
T.K.Kumar,
I.M.Chiu,
and
C.Yu
(2002).
Identification of rare partially unfolded states in equilibrium with the native conformation in an all beta-barrel protein.
|
| |
J Biol Chem, 277,
34941-34948.
|
 |
|
|
|
|
 |
H.J.Hecht,
R.Adar,
B.Hofmann,
O.Bogin,
H.Weich,
and
A.Yayon
(2001).
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
378-384.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.E.Robinson,
and
A.B.Robinson
(2001).
Prediction of protein deamidation rates from primary and three-dimensional structure.
|
| |
Proc Natl Acad Sci U S A, 98,
4367-4372.
|
 |
|
|
|
|
 |
S.R.Brych,
S.I.Blaber,
T.M.Logan,
and
M.Blaber
(2001).
Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a beta-trefoil.
|
| |
Protein Sci, 10,
2587-2599.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.N.Plotnikov,
S.R.Hubbard,
J.Schlessinger,
and
M.Mohammadi
(2000).
Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.
|
| |
Cell, 101,
413-424.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.F.Culajay,
S.I.Blaber,
A.Khurana,
and
M.Blaber
(2000).
Thermodynamic characterization of mutants of human fibroblast growth factor 1 with an increased physiological half-life.
|
| |
Biochemistry, 39,
7153-7158.
|
 |
|
|
|
|
 |
R.M.Lozano,
A.Pineda-Lucena,
C.Gonzalez,
M.Angeles Jiménez,
P.Cuevas,
M.Redondo-Horcajo,
J.M.Sanz,
M.Rico,
and
G.Giménez-Gallego
(2000).
1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor.
|
| |
Biochemistry, 39,
4982-4993.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Venkataraman,
Z.Shriver,
J.C.Davis,
and
R.Sasisekharan
(1999).
Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans.
|
| |
Proc Natl Acad Sci U S A, 96,
1892-1897.
|
 |
|
|
|
|
 |
K.M.Patrie,
M.J.Botelho,
K.Franklin,
and
I.M.Chiu
(1999).
Site-directed mutagenesis and molecular modeling identify a crucial amino acid in specifying the heparin affinity of FGF-1.
|
| |
Biochemistry, 38,
9264-9272.
|
 |
|
|
|
|
 |
N.Nagano,
E.G.Hutchinson,
and
J.M.Thornton
(1999).
Barrel structures in proteins: automatic identification and classification including a sequence analysis of TIM barrels.
|
| |
Protein Sci, 8,
2072-2084.
|
 |
|
|
|
|
 |
S.I.Blaber,
J.F.Culajay,
A.Khurana,
and
M.Blaber
(1999).
Reversible thermal denaturation of human FGF-1 induced by low concentrations of guanidine hydrochloride.
|
| |
Biophys J, 77,
470-477.
|
 |
|
|
|
|
 |
I.Leconte,
J.C.Fox,
H.S.Baldwin,
C.A.Buck,
and
J.L.Swain
(1998).
Adenoviral-mediated expression of antisense RNA to fibroblast growth factors disrupts murine vascular development.
|
| |
Dev Dyn, 213,
421-430.
|
 |
|
|
|
|
 |
S.Faham,
R.J.Linhardt,
and
D.C.Rees
(1998).
Diversity does make a difference: fibroblast growth factor-heparin interactions.
|
| |
Curr Opin Struct Biol, 8,
578-586.
|
 |
|
|
|
|
 |
T.D.Osslund,
R.Syed,
E.Singer,
E.W.Hsu,
R.Nybo,
B.L.Chen,
T.Harvey,
T.Arakawa,
L.O.Narhi,
A.Chirino,
and
C.F.Morris
(1998).
Correlation between the 1.6 A crystal structure and mutational analysis of keratinocyte growth factor.
|
| |
Protein Sci, 7,
1681-1690.
|
 |
|
|
|
|
 |
A.Romero,
A.Pineda-Lucena,
and
G.Giménez-Gallego
(1996).
X-ray structure of native full-length human fibroblast-growth factor at 0.25-nm resolution.
|
| |
Eur J Biochem, 241,
453-461.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|